Ozempic 411: For Weight Loss, Diabetes, or Both?
The drug has become a pop culture darling after its weight loss potential was promoted on social media.
March 01 2023 5:06 PM
By continuing to use our site, you agree to our Private Policy and Terms of Use.
The drug has become a pop culture darling after its weight loss potential was promoted on social media.
The groups say the insurance company is unjustly cranking up the prices of HIV meds.Â
The drug company revealed promising long-term data at the 2022 Glasgow HIV conference, including news on cure development.
Lazaro Hernandez is facing 100 years in jail, but a judge released him just in time for the holiday weekend.
Authorities say the man faces 100 years in prison for allegedly selling altered, repackaged HIV medications to unsuspecting pharmacies.
The FDA approved this long-acting HIV prophylaxis late last year.
The biopharmaceutical company said it was working with authorities to remove the affected bottles from circulation.Â
The Biden administration has directed the companies to not charge copays or deductibles for medicine, labs, or office visits.
A new treatment in very early stages of review by the Food and Drug Administration found success in one individual.
A national HIV-focused pharmacy is combining resources with three other companies that offer meds to underserved communities.
While officials struggle to replenish an enormous budget deficit worsened by the pandemic, the health of thousands of people living with HIV hangs in the balance.
A proposed bill could have devastating effects for anyone on medication, including people living with HIV.
President Biden must rescind a last-minute Trump rule that could leave people with HIV on the hook for thousands in prescription costs.
A new study finds hope in sativa strains of cannabis.
Scientists found no improvement in the recovery or death rate of patients given the drug combo.
The practice complicates getting meds during a time when it's already difficult.
The FDA expanded approval of ViiV Healthcare's Dovato, making it available to HIV-positive people not new to treatment.
Researchers advise proceeding with caution, though, as the treatment may interfere with the body's ability to fight fungal infections.
A survey from the World Health Organization found dozens of countries face a "critically low" stockpile of live-saving pills.
ViiV Healthcare's Rukobia will treat HIV-positive people dealing with drug resistance or intolerance.